The Search for an HIV Vaccine Continues
May 18th 2021May 18 is HIV Vaccine Awareness Day. Here we explore just a few of the many reasons why a vaccine that is effective at preventing the acquisition of HIV and at reducing the viral load in those currently living with HIV remains an elusive goal.
Read More
Interview: Tanya Siddiqi, MD, Discusses the Promise of Reduced Toxicity With Liso-Cel
February 16th 2021Tanya Siddiqi, MD, director of the chronic lymphocytic leukemia program at Toni Stephenson Lymphoma Center provides insights on what the arrival of liso-cel could mean in the treatment landscape.
Read More
Employers: Innovators and Partners in the Delivery of More Effective and Equitable Cancer Care
December 24th 2020Employers have the focus, innovative mindset, analytical tools, and drive to partner effectively with innovative cancer care entities to bring better care to their respective members.
Read More
Reimagining Cancer Care Delivery—and Serving Employers—Through Access Hope
December 18th 2020In an interview with Evidence-Based Oncology™, City of Hope's Harlan Levine discussed the rising interest of employers in cancer care and how AccessHope can help them deliver better care where their employees live.
Read More
Black People More Likely Than Others to Die From Colorectal Cancer Spreading to the Liver
September 9th 2020Social reform to eliminate health disparities is necessary so that Black people, the most vulnerable group for advanced colorectal cancer, get the care they need for a disease that is curable if caught early, says City of Hope expert.
Read More
Zaia Draws on Decades of Innovation in Infectious Disease for Breakthroughs in Gene Therapy
June 17th 2020Known as a gene therapy pioneer, Zaia has spent almost 40 years at City of Hope, in Duarte, California. He was first drawn by the promise of studying cytomegalovirus. Over the decades, his groundbreaking research has encompassed HIV/AIDS, cellular gene transfer therapy, immunotherapy, bispecific antibodies, and now hyperimmune globulin for workers on the frontlines of the coronavirus disease 2019 (COVID-19) pandemic.
Read More